Search
glucagon receptor agonist
Indications:
- treatment of diabetes mellitus type-2 in the triple function hypoglycemic agent retatrutide
Interactions
drug interactions
drug adverse effects of hypoglycemic agents
Related
glucagon receptor; GL-R (GCGR)
glucagon; contains: glicentin; glicentin-related polypeptide; GRPP; oxyntomodulin; OXM; OXY; glucagon-like peptide 1; GLP-1; glucagon-like peptide 1(7-37); GLP-1(7-37); glucagon-like peptide 1(7-36); GLP-1(7-36); glucagon-like peptide 2; GLP-2 (GCG)
Specific
retatrutide
General
parenteral hypoglycemic agent
References
- Zoler ML
Triple Agonist Retatrutide Hits New Weight-Loss Highs.
Medscape. June 26, 2023
https://www.medscape.com/viewarticle/993714
- Jastreboff AM, Kaplan LM, Frias JP et al
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.
N Engl J Med. 2024. Jun 26.
PMID: 37366315
https://www.nejm.org/doi/full/10.1056/NEJMoa2301972